123MO Monalizumab, cetuximab and durvalumab in first-line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): A phase II trial
2021 ◽
Vol 32
◽
pp. S1432
D.A. Colevas
◽
K. Misiukiewicz
◽
A.T. Pearson
◽
J. Fayette
◽
J.R. Bauman
◽
...
2011 ◽
Vol 29
(15_suppl)
◽
pp. 5567-5567
◽
J. Guigay
◽
J. Fayette
◽
A. Dillies
◽
C. Sire
◽
J. N. Kerger
◽
...
G. Obara
◽
J. Sun
◽
D. Loo
◽
C. Bohac
2018 ◽
Vol 29
(4)
◽
pp. 1004-1009
◽
M. Tahara
◽
N. Kiyota
◽
T. Yokota
◽
Y. Hasegawa
◽
K. Muro
◽
...
2010 ◽
Vol 28
(15_suppl)
◽
pp. 5531-5531
◽
C. Le Tourneau
◽
E. Winquist
◽
S. J. Hotte
◽
S. A. Laurie
◽
D. Soulieres
◽
...
2011 ◽
Vol 29
(15_suppl)
◽
pp. 5561-5561
◽
L. L. Siu
◽
S. J. Hotte
◽
S. A. Laurie
◽
S. Singh
◽
E. Winquist
◽
...
2016 ◽
Vol 34
(15_suppl)
◽
pp. 6026-6026
◽
Makoto Tahara
◽
Naomi Kiyota
◽
Tomoya Yokota
◽
Yasuhisa Hasegawa
◽
Kei Muro
◽
...
2013 ◽
Vol 24
(3)
◽
pp. 761-769
◽
A.R. Abdul Razak
◽
D. Soulières
◽
S.A. Laurie
◽
S.J. Hotte
◽
S. Singh
◽
...
Close
Export Citation Format
Close
Share Document
Close